Clinical Trials By Fire with Jane Myles
Jane Myles is the Vice President of Clinical Trial Innovation at Curebase, a platform at the forefront of "decentralized trials." What does that mean? Well, when a patient qualifies and—hopefully—enrolls in a trial, they usually have to take up residence in a different city and uproot their lives for a few weeks or months. The idea behind decentralizing them means all the medications and protocols come to a patient's local hospital so as not to cause such unnecessary upheaval. Jane is also a musician at heart, so there's a bunch of non-science geekery afoot. Enjoy the show.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Jane Myles is the Vice President of Clinical Trial Innovation at Curebase, a platform at the forefront of "decentralized trials." What does that mean? Well, when a patient qualifies and—hopefully—enrolls in a trial, they usually have to take up residence in a different city and uproot their lives for a few weeks or months. The idea behind decentralizing them means all the medications and protocols come to a patient's local hospital so as not to cause such unnecessary upheaval. Jane is also a musician at heart, so there's a bunch of non-science geekery afoot. Enjoy the show.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
